Worth reading
57In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
4.3
%Wording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance of paid stock options (stock acquisition rights)
Who receives how much
678,300 common shares (6,783 stock acquisition rights × 100 shares)
3 directors of the Company6,783 stock acquisition rights (equivalent to 678,300 common shares)
The lower thin line represents the existing number of shares to which these shares will be added.
¥800 per stock acquisition right
Total issue value
¥5,426,400
Total Stock-Based Compensation
Not applicable (This is a paid issuance based on individual investment decisions, not compensation.)
Existing Shares and Increase
+4.30%Rate of increase
15,775,066 shares16,453,366Shares
4.3% (if all of these stock acquisition rights are exercised)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
The initial exercise price is ¥1,055 per share. Adjustment provisions apply in connection with stock splits, consolidations of shares, and the issuance of new shares or disposal of treasury shares at a price below market value, among other events. The minimum exercise price is Not disclosed.
Exercise period
Start Date 1 October 2028 / End date 9 September 2036
Number of Stock Acquisition Rights
Total number issued: 6,783. The number of outstanding unexercised rights is Not disclosed.
Reason for acquisition without consideration
If a merger or other transaction in which the Company is the disappearing company is approved, or if a holder of the stock acquisition rights becomes unable to exercise the rights, the Company may acquire the stock acquisition rights without consideration.
Categories and Number of Persons Covered
3 directors of the Company; 6,783 stock acquisition rights allocated
Payment date
10 September 2026
Basis for determining the amount to be paid
The amount was determined with reference to the results of a Monte Carlo simulation conducted by 株式会社プルータス・コンサルティング, an independent valuation institution, taking into account the Company’s share price information and other factors. The periods used for the closing price and average share price, as well as the discount and premium rates, are Not disclosed.
Procedures under the Corporate Code of Conduct
Because the rights will be issued for consideration at fair value and on terms that are not particularly favorable, the issuance will be carried out without shareholder approval. The issue price was determined with reference to the valuation by an independent valuation institution.
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of paid stock options (stock acquisition rights) |
| Number of shares to be issued or disposed of | 678,300 common shares (6,783 stock acquisition rights × 100 shares) |
| Issue price and disposal price | ¥800 per stock acquisition right |
| Total issue value | ¥5,426,400 |
| Payment date | 10 September 2026 |
| Intended allottee | Name 3 directors of the Company / Number of Shares 6,783 stock acquisition rights (equivalent to 678,300 common shares) |
| Dilution Rate | 4.3% (if all of these stock acquisition rights are exercised) |
| Total number of issued shares | 15,775,066 shares → 16,453,366 shares (if all stock acquisition rights are exercised)（4.3％） |
| Basis for determining the amount to be paid | The amount was determined with reference to the results of a Monte Carlo simulation conducted by 株式会社プルータス・コンサルティング, an independent valuation institution, taking into account the Company’s share price information and other factors. The periods used for the closing price and average share price, as well as the discount and premium rates, are Not disclosed. |
| Exercise price | The initial exercise price is ¥1,055 per share. Adjustment provisions apply in connection with stock splits, consolidations of shares, and the issuance of new shares or disposal of treasury shares at a price below market value, among other events. The minimum exercise price is Not disclosed. |
| Exercise period | Start Date 1 October 2028 / End date 9 September 2036 |
| Number of Stock Acquisition Rights | Total number issued: 6,783. The number of outstanding unexercised rights is Not disclosed. |
| Reason for acquisition without consideration | If a merger or other transaction in which the Company is the disappearing company is approved, or if a holder of the stock acquisition rights becomes unable to exercise the rights, the Company may acquire the stock acquisition rights without consideration. |
| Categories and Number of Persons Covered | 3 directors of the Company; 6,783 stock acquisition rights allocated |
| Total Stock-Based Compensation | Not applicable (This is a paid issuance based on individual investment decisions, not compensation.) |
| Procedures under the Corporate Code of Conduct | Because the rights will be issued for consideration at fair value and on terms that are not particularly favorable, the issuance will be carried out without shareholder approval. The issue price was determined with reference to the valuation by an independent valuation institution. |
Items this document does not state (12)
Amount of funds to be raisedEstimated issuance expensesSpecific use of fundsIntended allottee's holding policyTransfer restriction periodConditions for lifting transfer restrictionsUnderwriter / lead underwriterOverallotmentStock Split RatioMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To increase the directors’ motivation, morale, commitment to enhancing corporate value and unity in pursuit of the Company’s medium- to long-term earnings growth and increased corporate value. The Company believes that making the achievement of targets for adjusted operating profit and market capitalization conditions for exercising the rights will contribute to the interests of existing shareholders and that the impact of dilution is reasonable.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.